Ab Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

10.30EUR
5:40am EDT
Price Change (% chg)

€0.07 (+0.68%)
Prev Close
€10.23
Open
€10.39
Day's High
€10.39
Day's Low
€10.27
Volume
1,609
Avg. Vol
35,370
52-wk High
€22.30
52-wk Low
€10.06

ABS.PA

Chart for ABS.PA

About

AB Science SA is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is cpecialized in tageted therapies through tyrosine kinase inhibitors for treating diseases with high medical in the field of cancers, chronic inflammatory diseases,... (more)

Overall

Beta: 0.95
Market Cap (Mil.): €336.82
Shares Outstanding (Mil.): 32.93
Dividend: --
Yield (%): --

Financials

  ABS.PA Industry Sector
P/E (TTM): -- 35.07 35.49
EPS (TTM): -0.45 -- --
ROI: -56.93 18.94 18.21
ROE: -557.67 19.73 19.11
Search Stocks

AB Science loses appeal over EU rejection of cancer drug

LONDON - French biotech company AB Science has lost an appeal to get the London-based European Medicines Agency to reconsider its rejection of the company's cancer drug Masican, originally handed down in November.

21 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks